J&J resumes doses in EU; booster shots likely needed & more: 4 updates on the COVID-19 vaccine

Here are four updates on the COVID-19 vaccine over the past week:

Advertisement

1. Johnson & Johnson said April 20 it is resuming its COVID-19 vaccine shipments to the European Union, Norway and Iceland. The European Medicines Agency recommended the vaccine should have a label warning about the rare possibility of blood clots.

2. Half of American adults — 131.2 million people — have received at least one dose of a COVID-19 vaccine as of April 18.

3. Pfizer CEO Albert Bourla, PhD, said April 15 that people will likely need a third COVID-19 shot six to 12 months after they’re fully vaccinated. 

4. Most Americans enthusiastic about getting vaccinated against COVID-19 will receive their shots by mid-May, according to a Kaiser Family Foundation analysis.

More articles on surgery centers:
8 joint-venture ASCs opened or announced recently
Kaiser Permanente in 2021: 5 ASC moves
USPI’s Q1 case volume down 6.5% from 2019: 5 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.